B-Cell Neoplasm — Trials

B-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 594 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06854159	Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy	recruiting	Phase 2	34	University of California, DavisOTHER	1	Jul 8, 2026	clinicaltrials
NCT07657312	Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma	recruiting	Phase 2	35	Naresh BummaOTHER	1	Jul 8, 2026